CHEMICAL PENETRATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY SYSTEM
In present scenario more than 70% of the drugs that are taken by oral route are found to be less effective as desired, to overcome this constraint Transdermal drug delivery system has emerged as an innovative area of research, this system helps in delivering the drugs and macromolecules through skin into systemic circulation. At present, the worldwide market of Transdermal patch has reached 2 billion pounds. Many drugs like Estrogen, Progestrone, Nitroglycerine, Clonodine etc. are fabricated in form of Transdermal patches due to its ability to deliver the drug in non-invasive manner and also to overcome the problems associated with oral route. Although the Transdermal patches deliver the drug at predetermined rate1, the partitioning of drug from the system to the skin and then penetration through different layers of skin can be altered by adding penetration enhancers that can be physical or chemical in nature. This article deals with the role of different chemicals that can be used as penetration enhancer.
Keywords: Penetration enhancer, Layer of skin, Fatty alcohol and glycol
3. Pandey A, Mittal A, Chauhan N, Alam S, Role of Surfactants as Penetration Enhancer in Transdermal Drug Delivery System. Journla of Molecular Pharmaceutics of journal & Organic Process Research, 2014; 2(2):2-10.
4. Dragicevic N., Atkinson J.P, Maibach H.I, Chemical Penetration Enhancers: Classification and Mode of Action. In: Dragicevic N., Maibach H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg, (2015).
5. Reiger MM, Rhein LD. Surfactant in Cosmetics. Vol. 68. New York: Marcel Dekker; 1997.
6. Kandimalla K, Kanikkannan N, Andega S, Singh M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo. Journal of Pharmacy and Pharmacology, 1999; (51):783–90.
7. Perhing L.K.; Lambert L.D. and Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharmaceutical. Research, 1990; 7(2):170-175.
8. El-Kattan AF Asbill CS Michniak B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. International Journal of Pharmceutics, 2000, 5; 198(2):179-89.
9. Lan Y, Li H, Chen Y, Zhang Y, Liu N, Zhang Q, Wu Q, Essential oil from Zanthoxylum bungeanum Maxim. and its main components used as transdermal penetration enhancers: A comparative study. Journal of Zhejiang University Science, 2014; 15(11):940–952.
10. Furuishi T, KatoY, Fukami T, Suzuki T, Endo T, Nagase H, Ueda H, Tomono K, Effect of terpenes on the skin permeation of lomerizine dihydrochloride. Journal of Pharmacy and Pharmacology Science, 2013; 16(4):551–563.
11. Wiliamsand AC, Barry BW, Skin absorption enhancers, Critical Reviews in Therapeutic Drug Carrier Systems, 1992; 305–353.
12. Horrocks Jr WD, Cotton FA, Infrared and Raman spectra and normal co-ordinate analysis of dimethyl sulfoxide and dimethyl sulfoxide-d6, Spectrochimica Acta 17, 1961; 17(2):134–147.
13. Barry BW, Southwell D, Woodford R. Optimization of bioavailability of topical steroid: penetration enhancers under occlusion. Journal of Investigative Dermatology 1984; 82:49-52.
14. Rhein LD, Robbins CR, Fernee K, Cantore R Surfactant structure effects on swelling of isolated human stratum corneum. Journal of Society Cosmetic Chemist, 1986; 37:125-139.
15. Gibson WT, Teall MR Interactions of C12 surfactants with the skin: changes in enzymes and visible and histological features of rat skin treated with sodium lauryl sulphate. Food and Chemical Toxicology, 1983; 21(5):587-594.
16. Kitagawa S, Kasamaki M, Ikarashi, A Effects of n-alkyl trimethyl ammonium on skin permeation of benzoic acid through excised guinea pig dorsal skin. Chemical and Pharmaceutical Bulletin (Tokyo), 2000; 48:1698-1701.
17. Breuer MM, The interaction between surfactants and keratinous tissues. Journal of Society Cosmetic Chemist, 1979; 30:41-64.
18. Ridout G, Hostynek JJ, Reddy AK, Wiersema RJ, Hodson CD, Lorence CR, The effects of zwitterionic surfactants on skin barrier function. Fundamental and applied toxicology, 1991; 16(1):41–50.
19. Williams A.C, Urea and Derivatives as Penetration Enhancers. In: Dragicevic N., Maibach H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg, (2015).
20. Singh PB, Choudhury PK, Penetration enhancers for transdermal drug delivery of systemic agents. Tropical Journal of Pharmaceutical Research, 2007; 6(5):44-50.
21. Prajapati Shailesh T, Patel CG, Patel C N, Formulation and Evaluation of Transdermal Patch of Repaglinide. International Scholarly Research Network, 2011; 1-9
22. Sheth NS, Mistry RB, Formulation and evaluation of transdermal patches and to study permeation enhancement effect of eugenol. Journal of Applied pharmaceutical sciences, 2011; 1(03):96-101.
23. Hanna E, Fakhry G, Effect of various penetration enhancer concentrations on diclofenac sodium release from cellulose acetate phthalate polymeric film. Asian journal of pharmaceutical sciences, 2011; 5(1):33-40.
24. Zhan X, Mao Z, Chen S, Chen S, Wang L, Formulation and evaluation of transdermal drug-delivery system of isosorbide dinitrate. Brazilian Journal of Pharmaceutical Sciences, 2015; 51(2):373-382.
25. Madan JR, Argade NS, Dua K, Formulation and evaluation of transdermal patches of Donepezil. Pub-med NCBI, 2015; 9(1):95-103.
26. Jadhav JK, Sreenivas SA, Formulation and In-vitro evaluation of Indomethacin transdermal patches using polymers HPMC E5 and ethyl cellulose. International Journal of Pharmacy and Pharmaceutical Sciences, 2012; 4(1):550-556.
27. Asifa R, Gupta A, Maheswarin BS, Formulation and evaluation of transdermal patches of Toresamide. International journal of advances in scientific research, 2015; 1(01):38-44.
28. Dhawan S, Hari KSL, Formulation and in-vitro evaluation of transdermal patches of containing of reserperidone. Drug Development and Industrial Pharmacy, 2013; 39(1):39-50.
29. Kumar R, Saini N, Saroha K, Formulation, optimization & evaluation of transdermal patches of salbutamol sulphate. International jurnal of pharmaceutical sciences and research, 2016; (4):1572-79.
30. David SRN, Rajaballaya R and Zhia ES, Development and in –vitro evaluation of self adhesive matrix type transdermal delivery system of Ondansetron Hydrochloride. Tropical journal of pharmaceutical research February, 2015; 14(2):211-218.
31. Zhang Y, Cun D, Kong X, Fang L, Design and evaluation of a novel transdermal patch containing Diclofenac and Teriflunamide for rheumatoid arithritis therapy. Asian Journal of pharmaceutical sciences, 2014; 251-259.
32. Agrarwal G, Dhawan S, Hari Kumar S, Formulation, in-vitro evaluation of matrix type transdermal patches containing Olanzapine. Pharmaceutical technology and development, 2013; 18(04):916-25.
33. Yousuf M, Ahmad M, Usman M. and Ali L, Formulation of transdermal patch of combination of Salbutamol and Ketotifin fumarate. Indian Journal of Pharmaceutical Sciences, 2013; 75(5):569-577.
34. Akhlaq M, Danish Z, Khan K, Saeed H, Fabrication of Flurbiprofen transdermal patch using Milk, thistle oil as permeation enhancer. Acta Poloniae pharmaceutica – drug research, 2017; 74(04):1187-1201.
35. Tirunagari M, Nandagopal A, Development and physicochemical, In Vitro and In vivo evaluation of Transdermal patches of Zaleplon. International Journal of Pharmaceutical Education and Research, 2013; 47(4):49-58.
36. Prabhakara P, Koland M, Vijaynarayana K, Harish NM, Shankar G, Ahmed MG, Preparation and Evaluation of Transdermal patches of Papaverine Hydrochloride. International Journal of Research in Pharmaceutical Sciences, 2010; 1(3):259-266.
37. Wang Y, Zhao X-P, and Ruan J-W, Transdermal delivery of Aceclofenac for Rheumatoid Arthritis and the effect of permeation enhancers, In vitro and In vivo characterization. International Journal of pharmacology, 2015; 11(5):456-462.
38. Karemore M N, Dandare M S, Belgamwar A V, Mundhada D R, Bhaskaran Dr. S, Design and evaluation of Carvedilol Transdermal patch using natural polymer. Journal Of Pharmacy Research, 2012; 5(10):4947-4949.
39. Revathi Mannam, Indira Muzib Yallamalli , Formulation Optimization and Study on Effect of Penetration Enhancers on Reservoir Transdermal Therapeutic Systems of Hydralazine Hydrochloride. Journal of Young Pharmacists, 2017; 9(4):513-518.
40. Banweer J, Pandey S, Pathak A K, Development and Optimization of Transdermal System of Lisinopril dehydrate: Employing Permeation Enhancers. Iranian Journal of Pharmaceutical Sciences, Autumn, 2010; 6(04):245-251.
41. Lakshmi PK, Mounika K and Saroja CH, Transdermal Permeation Enhancement of Lamotrigine Using Terpenes. Journal of J Pharmaceutical Care & Health Systems, 2014; 1(1):2-6.
42. Kharat RS, Bathe RS, Formulation and evaluation of transdermal patches of nicardipine hydrochloride. International journal of pharmacy & technology, 2016; 8(2):12609-12628.
43. Subramanian S, Keerthana Devi M., Vaiyana Rajesh C., Sakthi M, Suganya G, Ravichandran S, Preparation, Evaluation, and Optimization of Atorvastatin Nanosuspension Incorporated Transdermal Patch, 2016; 10(4):487-491.
44. Gadekar R, Saurabh M K, Thakur G S, Saurabh A. Study of formulation, characterization and wound Healing potential of transdermal patches of curcumin. Asian Journal of Pharmaceutical and clinical research, 2012; 50(4):225-230.
45. Bhaskar VN et al., Formulation and characterization of Simvastatin nanoparticle loaded transdermal patches. Journal of chemical and pharmaceutical research, 2015; 7(7):1084-1093
46. Dangi AA, Sheth ZP, Joshi J. Formulation and evaluation of transdermal Ondasteron Hydrochloride matrix patch: In vitro skin permeation and irritation styudy. International Journal of Pharmaceutical Research and Allied sciences, 2012; 1(2):26-37.
47. Vennapoosa S, Sandeep D, Formulation and evaluation of a matrix-type Transdermal patch containing Rivastigmaine Tartarate. International Journal of Pharmaceutical Science and Research, 2013; 4(2):10-16.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).